Please ensure Javascript is enabled for purposes of website accessibility

This Is the Best COVID Vaccine Stock Based on Warren Buffett's Investing Rules

By Keith Speights - Jan 15, 2021 at 6:16AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Really only one of the legendary investor's rules are needed.

Warren Buffett hasn't weighed in publicly about which coronavirus vaccine stocks are his favorites. However, it's possible to get a sense of what the Oracle of Omaha might think based on what he's said in the past. In this Motley Fool Live video recorded on Jan. 6, 2021, Healthcare and Cannabis Bureau Chief Corinne Cardina and writer Keith Speights discuss the best COVID vaccine stock based on Buffett's own investing rules.

Corinne Cardina: Let's kind of rapid-fire through a couple of last questions. Maybe we'll grab one more from Slido. You wrote an article on the one coronavirus vaccine stock you would buy right now. What is it and why?

Keith Speights: The stock is Johnson & Johnson (JNJ 0.84%). I blamed it on Warren Buffett, Corinne. [laughs] Anyone who follows Warren Buffett, legendary investor, he's famous for his two investing rules. Rule No. 1: don't lose money. Rule No. 2: Don't forget rule No. 1.

With Johnson & Johnson, you're just not going to lose money over the long run. Sure the stock hasn't been a tremendous performer over the last few years. But Johnson & Johnson has been around for a long, long time, I think since 1886 or something like that. It's been around a long time.

It's made its way through very difficult situations. It survived world wars and multiple pandemics and recessions and depressions and it survived and thrived. Over the long run, Johnson & Johnson will be a winner. I looked into which coronavirus stock has been the biggest millionaire maker of all. Guess what it was?

Cardina: Of course, Johnson & Johnson.

Speights: Johnson & Johnson, yeah. [laughs]. I think Johnson & Johnson is so big and is so diversified that it's just a safe bet. If I can only pick one stock, I'm going to take the safe route and that's why I went with Johnson & Johnson. I don't think it's going to be the biggest winter among these coronavirus stocks, but it's certainly one that I don't think is going to lose you money.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Johnson & Johnson Stock Quote
Johnson & Johnson
$178.33 (0.84%) $1.48

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.